U.S. flag

An official website of the United States government

Format
Items per page

Send to:

Choose Destination

Search results

Items: 1 to 20 of 905

  • The following terms were not found in MeSH: Gregory, Washburn.
1.

complications [Subheading]

Used with diseases to indicate conditions that co-exist or follow, i.e., co-existing diseases, complications, or sequelae.

Year introduced: 1966

2.

Organisation for Economic Co-Operation and Development

An international organization whose mission is to stimulate world trade and economic progress by offering a forum where governments can collectively develop and refine social and economic policies.

Year introduced: 2015

3.

Inducible T-Cell Co-Stimulator Ligand

A B7 antigen that binds specifically to INDUCIBLE T-CELL CO-STIMULATOR PROTEIN on T-CELLS. It provides a costimulatory signal for T-cell proliferation and cytokine secretion.

Year introduced: 2012(2000)

4.

Inducible T-Cell Co-Stimulator Protein

A costimulatory receptor that is specific for INDUCIBLE T-CELL CO-STIMULATOR LIGAND. The receptor is associated with a diverse array of immunologically-related effects including the increased synthesis of INTERLEUKIN 10 in REGULATORY T-LYMPHOCYTES and the induction of PERIPHERAL TOLERANCE.

Year introduced: 2012(1999)

5.

Nuclear Receptor Co-Repressor 2

A nuclear co-repressor protein that shows specificity for RETINOIC ACID RECEPTORS and THYROID HORMONE RECEPTORS. The dissociation of this co-repressor from nuclear receptors is generally ligand-dependent, but can also occur by way of its phosphorylation by members of the MAP KINASE SIGNALING SYSTEM. The protein contains two nuclear receptor interaction domains and four repressor domains and is closely-related in structure to NUCLEAR RECEPTOR CO-REPRESSOR 1.

Year introduced: 2010(1995)

6.

Nuclear Receptor Co-Repressor 1

A nuclear protein that regulates the expression of genes involved in a diverse array of processes related to metabolism and reproduction. The protein contains three nuclear receptor interaction domains and three repressor domains and is closely-related in structure to NUCLEAR RECEPTOR CO-REPRESSOR 2.

Year introduced: 2010(1995)

7.

Co-Repressor Proteins

A subclass of repressor proteins that do not directly bind DNA. Instead, co-repressors generally act via their interaction with DNA-BINDING PROTEINS such as a TRANSCRIPTIONAL SILENCING FACTORS or NUCLEAR RECEPTORS.

Year introduced: 2010

8.

K Cl- Cotransporters

A subclass of symporters that specifically transport POTASSIUM and CHLORIDE ions across cellular membranes. Potassium chloride cotransporters play roles in regulating cell volume and intracellular chloride concentration.

Year introduced: 2024(1989)

9.

Protein Modification, Translational

Any of the enzymatically catalyzed modifications of the individual AMINO ACIDS of PROTEINS, and enzymatic cleavage or crosslinking of peptide chains that occur pre-translationally (on the amino acid component of AMINO ACYL TRNA), co-translationally (during the process of GENETIC TRANSLATION), or after translation is completed (POST-TRANSLATIONAL PROTEIN PROCESSING).

Year introduced: 2005

10.

Codependency, Psychological

A relational pattern in which a person attempts to derive a sense of purpose through relationships with others.

Year introduced: 2020 (1992)

11.

Polylactic Acid-Polyglycolic Acid Copolymer

A co-polymer that consists of varying ratios of polylactic acid and polyglycolic acid. It is used as a matrix for drug delivery and for BONE REGENERATION.

Year introduced: 2019 (1984)

12.

poly(lactide-co-trimethylene carbonate) [Supplementary Concept]

formed by lipase-catalyzed ring-opening copolymerization of lactide and trimethylene carbonate; structure in first source

Date introduced: October 8, 1999

13.

poly(3-hydroxybutyrate)-co-(3-hydroxyvalerate) [Supplementary Concept]

structure given in first source

Date introduced: June 25, 1987

14.

Ergoloid Mesylates

A mixture of the mesylates (methane sulfonates) of DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and the alpha- and beta-isomers of DIHYDROERGOCRYPTINE. The substance produces a generalized peripheral vasodilation and a fall in arterial pressure and has been used to treat symptoms of mild to moderate impairment of mental function in the elderly.

Year introduced: 1992

16.

poly((vinyl-3-(diethylamino)propylcarbamate)-co-(vinyl acetate)-co-(vinyl alcohol))-graft-poly(lactic acid) [Supplementary Concept]

carrier for transmucosal peptide delivery; structure in first source

Date introduced: January 26, 2005

17.

poly((methyl methacrylate)-co-(methyl acrylate)-co-(methacrylic acid))-poly(lactide-co-glycolide) [Supplementary Concept]

a phase-transitional shielding layer designed to protect oral vaccine antigens from digestion

Date introduced: October 16, 2016

19.
20.

poly(ethyleneimine-co-lactamide-co-succinamide) [Supplementary Concept]

a biodegradable polymer for gene delivery; structure in first source

Date introduced: August 2, 2003

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Loading ...